http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105168227-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 |
| filingDate | 2015-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105168227-B |
| titleOfInvention | A kind of self-microemulsion soft capsules and preparation method thereof of ginseng hydrolysate PPT/PPD |
| abstract | The invention discloses a kind of self-microemulsion soft capsules and preparation method thereof of ginseng hydrolysate PPT/PPD, belong to technical field of medicine.The self-microemulsion soft capsules of the ginseng hydrolysate PPT/PPD of the present invention, content are made of ginseng hydrolysate PPT/PPD and pharmaceutic adjuvant；Wherein, the mass ratio of ginseng hydrolysate PPT/PPD and pharmaceutic adjuvant is：Ginseng hydrolysate PPT/PPD：Pharmaceutic adjuvant=1:6‑1:21；Pharmaceutic adjuvant includes oil phase, emulsifier and assistant for emulsifying agent, and oil phase, emulsifier and assistant for emulsifying agent are respectively Miglyol oil, Labrasol and Tween 20, and mass ratio is：Oil phase：Emulsifier：Assistant for emulsifying agent=1 2:4‑8:1‑5.Self-microemulsion soft capsules preparation method of the present invention：To make after ginseng hydrolysate PPT/PPD and pharmaceutic adjuvant mixing to be filled with after its is evenly dispersed soft capsule to get.The self-microemulsion soft capsules of ginseng hydrolysate PPT/PPD of the present invention, contain the pharmaceutic adjuvant with CYP450 inhibitory activity, can improve the oral administration biaavailability of PPT/PPD. |
| priorityDate | 2015-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.